123 related articles for article (PubMed ID: 8750363)
1. Concentration-guided strategies in drug development: experience with a cyclosporine analog in transplantation.
Kovarik JM; Mueller EA; Kallay Z; Smith HT; Lison AE; Arns W; Renner E
J Clin Pharmacol; 1995 Dec; 35(12):1136-43. PubMed ID: 8750363
[TBL] [Abstract][Full Text] [Related]
2. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.
Kovarik JM; Mueller EA; Richard F; Niese D; Halloran PF; Jeffery J; Paul LC; Keown PA
Transplantation; 1996 Sep; 62(6):759-63. PubMed ID: 8824473
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation.
Mueller EA; Kovarik JM; van Bree JB; Lison AE; Kutz K
Transplantation; 1994 Apr; 57(8):1178-82. PubMed ID: 8178343
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and patient acceptance of cyclosporine soft gelatin capsules in renal allograft recipients.
Min DI; Hwang GC; Bergstrom S; Madras PN; Shaffer D; Sahyoun AI; Monaco AP
Ann Pharmacother; 1992 Feb; 26(2):175-9. PubMed ID: 1554925
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine bioequivalence study: quantification using fluorescence polarization immunoassay (FPIA) and radioimmunoassay (RIA).
Mendes GD; de Oliveira CH; Sucupira M; Donato JL; Moreno RA; De Nucci G
Int J Clin Pharmacol Ther; 2004 Feb; 42(2):125-32. PubMed ID: 15180174
[TBL] [Abstract][Full Text] [Related]
6. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Canadian Neoral Renal Transplantation Study Group
Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients.
Kovarik JM; Mueller EA; van Bree JB; Flückiger SS; Lange H; Schmidt B; Boesken WH; Lison AE; Kutz K
Transplantation; 1994 Sep; 58(6):658-63. PubMed ID: 7940685
[TBL] [Abstract][Full Text] [Related]
8. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.
Wahlberg J; Wilczek HE; Fauchald P; Nordal KP; Heaf JG; Olgaard K; Hansen JM; Lokkegaard H; Mueller EA; Kovarik JM
Transplantation; 1995 Oct; 60(7):648-52. PubMed ID: 7570970
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic comparison of the corn oil versus microemulsion gelcap formulation of cyclosporin used de novo after renal transplantation.
Amante AJ; Meier-Kriesche HU; Schoenberg L; Kahan BD
Transpl Int; 1997; 10(3):217-22. PubMed ID: 9163863
[TBL] [Abstract][Full Text] [Related]
11. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent.
Kaplan B; Meier-Kriesche HU; Napoli KL; Kahan BD
Clin Pharmacol Ther; 1998 Jan; 63(1):48-53. PubMed ID: 9465841
[TBL] [Abstract][Full Text] [Related]
12. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
Schädeli F; Marti HP; Frey FJ; Uehlinger DE
Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence of Neoplanta capsule to Sandimmune Neoral, microemulsion formulations of cyclosporin A in human subjects.
Lee YJ; Chung SJ; Shim CK
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):210-5. PubMed ID: 9587047
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
Kees F; Bucher M; Schweda F; Gschaidmeier H; Burhenne J; Mikus G; Faerber L
Ther Drug Monit; 2006 Jun; 28(3):312-20. PubMed ID: 16778713
[TBL] [Abstract][Full Text] [Related]
16. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral.
Ritschel WA
Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group.
Barone G; Chang CT; Choc MG; Klein JB; Marsh CL; Meligeni JA; Min DI; Pescovitz MD; Pollak R; Pruett TL; Stinson JB; Thompson JS; Vasquez E; Waid T; Wombolt DG; Wong RL
Transplantation; 1996 Mar; 61(6):875-80. PubMed ID: 8623152
[TBL] [Abstract][Full Text] [Related]
18. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the conventional and microemulsion formulations of cyclosporine in pancreas-kidney transplant recipients with gastroparesis.
van der Pijl JW; Srivastava N; Denouël J; Burggraaf J; Schoemaker RC; van der Woude FJ; Cohen AF
Transplantation; 1996 Aug; 62(4):456-62. PubMed ID: 8781610
[TBL] [Abstract][Full Text] [Related]
20. Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients.
Kovarik JM; Mueller EA; van Bree JB; Arns W; Renner E; Kutz K
Ther Drug Monit; 1994 Jun; 16(3):232-7. PubMed ID: 8085277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
